Peter Salgo, MD, and John L. Fox, MD, MHA, discuss the definition of predictive value of diagnostic testing in cancer and describe the value of the genomic assays that are currently available in ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

New University of Utah research reveals the potential of medication informatics and DNA drug-sensitivity testing to reduce overall healthcare resource use and costs in elderly patients treated with ...